2026-03-19 • PR Newswire
Vapendavir, Altesa BioSciences’ treatment of rhinovirus infections in individuals with respiratory illnesses, will be presented orally at the International Society for Antiviral Research Conference ICAR 22026-03-19 • PR Newswire
Vapendavir, Altesa BioSciences’ treatment of rhinovirus infections in individuals with respiratory illnesses, will be presented orally at the International Society for Antiviral Research Conference ICAR 22026-03-12 • stocktitan.net
NanoViricides will showcase at the NIBA’s 152nd Investment Conference in Fort Lauderdale, FL on March 12, 2026 – and reports the production of2026-03-11 • upi.com
Hyundai Bioscience participates in dengue fever clinical trial in Vietnam2026-03-10 • nextinvestors.com
ILA will evaluate current medications for three times as many newly identified viral illnesses2026-03-09 • smallcaps.com.au
Island Pharma Broadens Viral Treatment Development Through Burnet Institute Partnership and NHMRC Support2026-03-07 • manilatimes.net
Atea Pharmaceuticals Announces 2025 Fourth Quarter and Full Year Financials and a Business Overview2026-03-07 • en.vietnamplus.vn
Vietnam is testing the first oral antiviral drug for dengue fever in clinical trials2026-03-04 • pharmatimes.com
ProLectin‑M showed favorable phase 1b/2a outcomes according to Bioxytran’s findings.2026-03-04 • stocktitan.net
ProLectin-M Shows Promise in Early Trials as Bioxytran, Inc. Announces Positive Phase 1b/2a Clinical Study Results for the Broad-Range Antiviral Drug in Mild2026-02-28 • cidrap.umn.edu
Tpoxx shows no benefit over placebo in key mpox outcomes, phase 3 trial reveals.2026-02-27 • clinicaltrialsarena.com
DOR/ISL Phase III results confirm a growing preference for combination HIV treatments using two drugs.7 minutes ago • prnewswire.co.uk
Fortrade Tracks Energy Market Volatility as Geopolitical Risks Influence Global Markets37 minutes ago • prnewswire.co.uk
New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress37 minutes ago • prnewswire.co.uk
Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial6 hours ago • prnewswire.co.uk
Deye’s 2026 Frankfurt Distributor and Partner Summit Ended Positively2026-03-21 • prnewswire.co.uk
Shareholder Lawsuit Filed Against Goeasy Ltd.21 minutes ago • EIN Presswire
Hughey Law Firm Surpasses $300 Million in Verdicts & Settlements, Nearly Half Recovered for Elder Abuse Injury Victims21 minutes ago • EIN Presswire
Premiere Screening of 'Love in Storytown' Comes to Historic Jackson Theatre on April 1221 minutes ago • EIN Presswire
Property Trade Network Launches Cash Offer Platform for Home Sellers7 minutes ago • prnewswire.co.uk
Fortrade Tracks Energy Market Volatility as Geopolitical Risks Influence Global Markets7 minutes ago • prnewswire.co.uk
Propel taps investors in £306m debut issueStay ahead with real-time headlines from top sources, categorized by sector and country.